Fulgent Genetics(FLGT) - 2025 Q4 - Annual Results

Exhibit 99.1 Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results EL MONTE, CA, February 27, 2026 — Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Results: Full Year 2025 Results: Non-GAAP income (loss), non-GAAP income (loss) per share, a ...